However, in ERBB2+ breast cancer, the highly elevated levels of ERBB2 lead to a violation of these physiological constraints and the formation of both ERBB2 homodimers and ligand-independent heterodimers [14, 15]. The gene discussed is ERBB2; the disease is breast carcinoma.